Michel A. Duchosal

3.3k total citations
69 papers, 2.2k citations indexed

About

Michel A. Duchosal is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Michel A. Duchosal has authored 69 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 20 papers in Hematology and 20 papers in Immunology. Recurrent topics in Michel A. Duchosal's work include Chronic Myeloid Leukemia Treatments (12 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Michel A. Duchosal is often cited by papers focused on Chronic Myeloid Leukemia Treatments (12 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). Michel A. Duchosal collaborates with scholars based in Switzerland, Italy and United States. Michel A. Duchosal's co-authors include Laurent A. Décosterd, Nicolas Widmer, Thierry Buclin, Frank J. Dixon, Serge Leyvraz, Michael Montemurro, Amina Haouala, Patricia J. McConahey, Aimable Nahimana and Bertrand Rochat and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

In The Last Decade

Michel A. Duchosal

66 papers receiving 2.1k citations

Peers

Countries citing papers authored by Michel A. Duchosal

Since Specialization

Citations

This map shows the geographic impact of Michel A. Duchosal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel A. Duchosal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel A. Duchosal more than expected).

Fields of papers citing papers by Michel A. Duchosal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel A. Duchosal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel A. Duchosal. The network helps show where Michel A. Duchosal may publish in the future.

Co-authorship network of co-authors of Michel A. Duchosal

This figure shows the co-authorship network connecting the top 25 collaborators of Michel A. Duchosal. A scholar is included among the top collaborators of Michel A. Duchosal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel A. Duchosal. Michel A. Duchosal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identifying the drivers of overall rating of cancer care: Insights from the second wave of the Swiss Cancer Patient Experiences study 2024 ·Cancer ·(unknown), Manuela Eicher, Isabelle Peytremann‐Bridevaux, Stefan Aebi, Sandro Anchisi, Adrienne Bettini, Yves Chalandon, Pierre‐Yves Dietrich, Michel A. Duchosal, (unknown), Solange Peters, Roger von Moos, Andreas Wicki, Chantal Arditi	1
2	Nicotinaldehyde, a Novel Precursor of NAD Biosynthesis, Abrogates the Anti-Cancer Activity of an NAD-Lowering Agent in Leukemia 2023 ·Cancers ·Saki Matsumoto, (unknown), (unknown), Michel A. Duchosal, Aimable Nahimana	2
3	Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological Malignancies 2023 ·Molecules ·(unknown), Saki Matsumoto, (unknown), (unknown), Jian‐Fei Bai, Somi Reddy Majjigapu, (unknown), Dany Spaggiari, Vincent Desfontaine, Francesco Piacente, Santina Bruzzone, Michele Cea, Laurent A. Décosterd, Pierre Vogel, Alessio Nencioni, Michel A. Duchosal, Aimable Nahimana	4
4	Synthesis and structure-activity relationship of new nicotinamide phosphoribosyltransferase inhibitors with antitumor activity on solid and haematological cancer 2023 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Antonio J. Moreno‐Vargas, Ana T. Carmona, Aimable Nahimana, Michel A. Duchosal, Francesco Piacente, Santina Bruzzone, Irene Caffa, Alessio Nencioni, Inmaculada Robina	7
5	Gut microbiota severely hampers the efficacy of NAD-lowering therapy in leukemia 2022 ·Cell Death and Disease ·(unknown), Saki Matsumoto, (unknown), (unknown), Karin Schaeuble, Francesco Piacente, Héctor Gallart‐Ayala, Julijana Ivanišević, Ivan Stamenkovic, Alessio Nencioni, Aimable Nahimana, Michel A. Duchosal	9
6	Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells 2018 ·European Journal of Medicinal Chemistry ·Claudia Bello, Jian‐Fei Bai, (unknown), (unknown), Consuelo Gajate, Inmaculada Robina, Irene Caffa, Michele Cea, Fabrizio Montecucco, Alessio Nencioni, Aimable Nahimana, (unknown), (unknown), Michel A. Duchosal, Faustino Mollinedo, Pierre Vogel	6
7	Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair 2017 ·Cancer Research ·Francesco Piacente, Irene Caffa, Silvia Ravera, Giovanna Sociali, Mario Passalacqua, Valerio Gaetano Vellone, Pamela Becherini, Daniele Reverberi, Fiammetta Monacelli, Alberto Ballestrero, Patrizio Odetti, Antonia Cagnetta, Michele Cea, Aimable Nahimana, Michel A. Duchosal, Santina Bruzzone, Alessio Nencioni	83
8	T315I clone selection in a Ph+ all patient under low‐dose ponatinib maintenance 2017 ·Clinical Case Reports ·(unknown), Mathilde Gavillet, Stavroula Masouridi‐Levrat, Michel A. Duchosal, Olivier Spertini	5
9	Nutritional support practices in hematopoietic stem cell transplantation centers: A nationwide comparison 2016 ·Nutrition ·Annic Baumgartner, Mario Bargetzi, Annika Bargetzi, (unknown), (unknown), Jakob Passweg, Urs Schanz, Panagiotis Samaras, Yves Chalandon, Claude Pichard, (unknown), Luciano Wannesson, Thomas Pabst, Michel A. Duchosal, U Hess, Zeno Stanga, Beat Müeller, Philipp Schüetz	37
10	Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland 2015 ·Swiss Medical Weekly ·Panagiotis Samaras, Mario Bargetzi, Daniel Betticher, Michel A. Duchosal, Dominik Heim, U Hess, Nicolas Ketterer, Erika Lerch, Thomas Matthes, Ulrich Mey, Thomas Pabst, Christian Taverna, Thilo Zander, Christoph Renner	4
11	Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial 2014 ·Cancer Chemotherapy and Pharmacology ·Verena Gotta, Nicolas Widmer, Laurent A. Décosterd, Yves Chalandon, Dominik Heim, Michael Gregor, Rudolf Benz, (unknown), Gabriela M. Baerlocher, Michel A. Duchosal, Chantal Csajka, Thierry Buclin	66
12	Clinical pharmacokinetics of imatinib and its therapeutic relevance 2013 ·IRIS ·Nicolas Widmer, Verena Gotta, Amina Haouala, J.F. Blanc, Margaret von Mehren, Michel A. Duchosal, Serge Leyvraz, Chantal Csajka, Laurent A. Décosterd, Thierry Buclin	2
13	High-dose therapy and autologous hematopoietic stem cell transplant in T-cell lymphoma: a single center experience 2013 ·Leukemia & lymphoma ·Anne Cairoli, Nicolas Ketterer, Stefano Barelli, Michel A. Duchosal	2
14	The anti-lymphoma activity of APO866, an inhibitor of nicotinamide adenine dinucleotide biosynthesis, is potentialized when used in combination with anti-CD20 antibody 2013 ·Leukemia & lymphoma ·Aimable Nahimana, (unknown), (unknown), Somi Reddy Majjigapu, Bernard Sordat, Pierre Vogel, Michel A. Duchosal	14
15	IFN-alpha PROMOTES PROLIFERATION OF DORMANT HSCS IN VIVO, MAKING THEM SUSCEPTIBLE TO ELIMINATION BY CHEMOTHERAPY 2008 ·Infoscience (Ecole Polytechnique Fédérale de Lausanne) ·Marieke Essers, Sandra Offner, William Blanco-Bose, Zoe Waibler, Ulrich Kalinke, Michel A. Duchosal, Andreas Trumpp	0
16	Mycosis Fungoides in a Lung Transplant Recipient with Advanced Ciclosporin Nephropathy: Management with Mechlorethamine and Subsequent Renal Transplantation 2008 ·Dermatology ·Emmanuel Laffitte, Jean-Pierre Venetz, John‐David Aubert, Michel A. Duchosal, Renato G. Panizzon, Manuel Pascual	6
17	Severe Pustular Eruption Associated with Imatinib and Voriconazole in a Patient with Chronic Myeloid Leukemia 2005 ·Dermatology ·(unknown), Emmanuel Laffitte, Nicolas Widmer, Laurent A. Décosterd, Michel A. Duchosal, Tibor Kovacsovics, Renato G. Panizzon	36
18	A recombinant rubella virus E1 glycoprotein as a rubella vaccine candidate 2004 ·Vaccine ·(unknown), (unknown), Alain R. Thierry, Nicola Beltraminelli, Pascal Cousin, Nicolás Fasel, Véronique Vallet, Stéphane Demotz, Michel A. Duchosal, Corinne Moulon	5
19	Unresponsiveness to Lymphoid-Mediated Signals at the Neonatal Follicular Dendritic Cell Precursor Level Contributes to Delayed Germinal Center Induction and Limitations of Neonatal Antibody Responses to T-Dependent Antigens 2003 ·The Journal of Immunology ·Maria Pihlgren, Chantal Tougne, Paola Bozzotti, Alma Fulurija, Michel A. Duchosal, Paul‐Henri Lambert, Claire‐Anne Siegrist	83
20	Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice. 1990 ·The Journal of Experimental Medicine ·Michel A. Duchosal, Patricia J. McConahey, Charles A. Robinson, Frank J. Dixon	127

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact